---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-030867"
form_type: "8-K"
ticker: "CORZ"
cik: "0001839341"
company_name: "Core Scientific, Inc./tx"
filed_at: "2022-11-28T23:59:59+00:00"
generated_at: "2026-06-21T12:50:28.874132+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Director Stacie Olivares resigns from Core Scientific board

## Summary
- Stacie Olivares resigned as a director effective November 21, 2022.
- Resignation not due to any disagreement with the board, management, or company operations.
- No replacement announced; no changes to board committee assignments specified.

## SEC filing metadata
- accession: 0001628280-22-030867
- form_type: 8-K
- ticker: CORZ
- cik: 0001839341
- company_name: Core Scientific, Inc./tx
- filed_at: 2022-11-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1839341/000162828022030867/0001628280-22-030867-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1839341/000162828022030867/core-20221121.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-030867
- JSON: https://secwatch.observer/filing/0001628280-22-030867.json
- Plain text: https://secwatch.observer/filing/0001628280-22-030867.txt

## Key facts
- Executive change
  Stacie Olivares resigned as Director at Core Scientific, Inc./tx.
  - Action: resigned
  - Role: Director
  source text: On November 21, 2022, Stacie Olivares informed the Board of Directors (the “Board”) of Core Scientific, Inc. (the “Company”) of her intention to resign as a director of the Board and any committees thereof effective November 21, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1839341/000162828022030867/0001628280-22-030867-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.